172 related articles for article (PubMed ID: 18453712)
21. Functional induction and de-induction of P-glycoprotein by St. John's wort and its ingredients in a human colon adenocarcinoma cell line.
Tian R; Koyabu N; Morimoto S; Shoyama Y; Ohtani H; Sawada Y
Drug Metab Dispos; 2005 Apr; 33(4):547-54. PubMed ID: 15640377
[TBL] [Abstract][Full Text] [Related]
22. [Hypericin and hyperforin: bioactive components of St. John's Wort (Hypericum perforatum). Their isolation, analysis and study of physiological effect].
Vacek J; Klejdus B; Kubán V
Ceska Slov Farm; 2007 Apr; 56(2):62-6. PubMed ID: 17619301
[TBL] [Abstract][Full Text] [Related]
23. Quantitative characterization of direct P-glycoprotein inhibition by St John's wort constituents hypericin and hyperforin.
Wang EJ; Barecki-Roach M; Johnson WW
J Pharm Pharmacol; 2004 Jan; 56(1):123-8. PubMed ID: 14980009
[TBL] [Abstract][Full Text] [Related]
24. Mood-enhancing antidepressant St. John's wort inhibits the activation of human immunodeficiency virus gene expression by ultraviolet light.
Taher MM; Lammering GM; Hershey CM; Valerie KC
IUBMB Life; 2002 Dec; 54(6):357-64. PubMed ID: 12665247
[TBL] [Abstract][Full Text] [Related]
25. [St. John's wort (Hypericum perforatum L.). A plant with relevance for dermatology].
Schempp CM; Müller KA; Winghofer B; Schöpf E; Simon JC
Hautarzt; 2002 May; 53(5):316-21. PubMed ID: 12063742
[TBL] [Abstract][Full Text] [Related]
26. Mechanism of action of St John's wort in depression : what is known?
Butterweck V
CNS Drugs; 2003; 17(8):539-62. PubMed ID: 12775192
[TBL] [Abstract][Full Text] [Related]
27. Drug-herb interaction: effect of St John's wort on bioavailability and metabolism of procainamide in mice.
Dasgupta A; Hovanetz M; Olsen M; Wells A; Actor JK
Arch Pathol Lab Med; 2007 Jul; 131(7):1094-8. PubMed ID: 17616997
[TBL] [Abstract][Full Text] [Related]
28. St John's Wort (Hypericum perforatum L.) photomedicine: hypericin-photodynamic therapy induces metastatic melanoma cell death.
Kleemann B; Loos B; Scriba TJ; Lang D; Davids LM
PLoS One; 2014; 9(7):e103762. PubMed ID: 25076130
[TBL] [Abstract][Full Text] [Related]
29. St John's wort (Hypericum perforatum L.): a review of its chemistry, pharmacology and clinical properties.
Barnes J; Anderson LA; Phillipson JD
J Pharm Pharmacol; 2001 May; 53(5):583-600. PubMed ID: 11370698
[TBL] [Abstract][Full Text] [Related]
30. Hypericin, a medicinal compound from St. John's Wort, inhibits genotoxicity induced by mutagenic agents in V79 cells.
de Souza LM; de Sousa FD; Cruz RCR; Tavares DC; Francielli de Oliveira P
Drug Chem Toxicol; 2022 May; 45(3):1302-1307. PubMed ID: 33050761
[TBL] [Abstract][Full Text] [Related]
31. Hyperforin a constituent of St John's wort (Hypericum perforatum L.) extract induces apoptosis by triggering activation of caspases and with hypericin synergistically exerts cytotoxicity towards human malignant cell lines.
Hostanska K; Reichling J; Bommer S; Weber M; Saller R
Eur J Pharm Biopharm; 2003 Jul; 56(1):121-32. PubMed ID: 12837490
[TBL] [Abstract][Full Text] [Related]
32. A systematic review and meta-analysis of Hypericum perforatum in depression: a comprehensive clinical review.
Whiskey E; Werneke U; Taylor D
Int Clin Psychopharmacol; 2001 Sep; 16(5):239-52. PubMed ID: 11552767
[TBL] [Abstract][Full Text] [Related]
33. Dissolution, solubility and cooperativity of phenolic compounds from Hypericum perforatum L. in aqueous systems.
Jürgenliemk G; Nahrstedt A
Pharmazie; 2003 Mar; 58(3):200-3. PubMed ID: 12685814
[TBL] [Abstract][Full Text] [Related]
34. St John's wort, hypericin, and imipramine: a comparative analysis of mRNA levels in brain areas involved in HPA axis control following short-term and long-term administration in normal and stressed rats.
Butterweck V; Winterhoff H; Herkenham M
Mol Psychiatry; 2001 Sep; 6(5):547-64. PubMed ID: 11526469
[TBL] [Abstract][Full Text] [Related]
35. The Biochemical and Genetic Basis for the Biosynthesis of Bioactive Compounds in
Rizzo P; Altschmied L; Ravindran BM; Rutten T; D'Auria JC
Genes (Basel); 2020 Oct; 11(10):. PubMed ID: 33081197
[No Abstract] [Full Text] [Related]
36. Understanding drug interactions with St John's wort (Hypericum perforatum L.): impact of hyperforin content.
Chrubasik-Hausmann S; Vlachojannis J; McLachlan AJ
J Pharm Pharmacol; 2019 Jan; 71(1):129-138. PubMed ID: 29411879
[TBL] [Abstract][Full Text] [Related]
37. The main components of St John's Wort inhibit low-density lipoprotein atherogenic modification: a beneficial "side effect" of an OTC antidepressant drug?
Laggner H; Schreier S; Hermann M; Exner M; Mühl A; Gmeiner BM; Kapiotis S
Free Radic Res; 2007 Feb; 41(2):234-41. PubMed ID: 17364950
[TBL] [Abstract][Full Text] [Related]
38. Temperature-dependent growth and hypericin biosynthesis in Hypericum perforatum.
Yao Y; Kang T; Jin L; Liu Z; Zhang Z; Xing H; Sun P; Li M
Plant Physiol Biochem; 2019 Jun; 139():613-619. PubMed ID: 31030029
[TBL] [Abstract][Full Text] [Related]
39. Screen of receptor and uptake-site activity of hypericin component of St. John's wort reveals sigma receptor binding.
Raffa RB
Life Sci; 1998; 62(16):PL265-70. PubMed ID: 9585174
[TBL] [Abstract][Full Text] [Related]
40. [Flavonoid and dianthranoid levels of the St.-John's-wort flowering tops].
Girzu-Amblard M; Carnat A; Fraisse D; Carnat AP; Lamaison JL
Ann Pharm Fr; 2000 Oct; 58(5):341-5. PubMed ID: 11060411
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
